Skip to main content
Fig. 7 | Hereditas

Fig. 7

From: Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment

Fig. 7

Cynarine inhibited fat deposition, reduced ALT and AST relief, and down-regulated AKT1 and MAPK1 expression in NAFLD model cells. A Comparison of oil red O staining and fat accumulation of cells in each group. B, C Comparison of the content of ALT and AST in the cell culture supernatant of each group. D, E, F The expression levels of AKT1 and MAPK1 in each group were detected. Compared with the control group: **P<0.01; compared with the model group: #P<0.05 or ##P<0.01

Back to article page

Hereditas

ISSN: 1601-5223

Contact us